Hundreds of trans patients admitted to hospital as women despite having conditions only suffered by MENThe FBI has been political from the start
When the cryptocurrency market moves, experts are suggesting a number of Solana alternatives that are primed to take off by Christmas. Although Solana has earned a reputation for its high transaction speed and scalability, there are other projects currently gathering momentum who are developing new and more interesting approaches to blockchain technology. One such project is Lightchain AI , which combines artificial intelligence with blockchain to offer scalable, decentralized applications across industries like healthcare, finance, and supply chain. In contrast to Solana, which is based on transaction speed, Lightchain AI applies its Proof of Intelligence (PoI) consensus mechanism and Artificial Intelligence Virtual Machine (AIVM) to provide AI-enabled and value-delivering solutions. At the presale price of $0.003, Lightchain AI presents an investment with long-term upside potential. With increasing demand for AI-powered decentralized applications, professionals have concluded that Lightchain AI is likely to rank higher than mature blockchains, hence exciting options to investors at holiday season. In this article, 4 Solana substitutes are presented to and discussed by experts who claim they will be explosive growth before Christmas. 4 Solana Alternatives to Keep an Eye On Here are four Solana alternatives that are gaining attention and could see significant growth: 1. Lightchain AI : Combining artificial intelligence with blockchain, Lightchain AI offers decentralized, AI-driven solutions for industries like healthcare, finance, and supply chain. Its Proof of Intelligence (PoI) consensus and Artificial Intelligence Virtual Machine (AIVM) make it a unique project set for long-term success. With its presale priced at $0.003, Lightchain AI presents an exciting investment opportunity. 2. Polkadot (DOT) : Polkadot is focused on creating an interoperable multi-chain network, allowing different blockchains to communicate with one another. Its scalability and cross-chain compatibility make it an attractive option for decentralized applications. 3. Avalanche (AVAX) : Avalanche offers high-speed, low-cost transactions and is known for its subnets, allowing developers to create customized blockchains that meet specific needs. It's a strong competitor in DeFi and enterprise blockchain solutions. 4. Cardano (ADA) : Cardano emphasizes sustainability, scalability, and security, using a proof-of-stake consensus mechanism. It’s a leader in providing decentralized applications (dApps) with a focus on global real-world impact, especially in developing regions. These alternatives to Solana each bring unique strengths and are poised for substantial growth in the next market cycle. Experts recommend keeping a close eye on these projects and considering them for investment opportunities this holiday season. Why Solana Alternatives Are Worth Considering Solana alternatives like Lightchain AI, Polkadot, Avalanche, and Cardano are gaining attention for their unique strengths, offering investors valuable opportunities. Lightchain AI stands out with its integration of artificial intelligence and blockchain, providing scalable, AI-powered decentralized applications that tackle real-world challenges in sectors such as healthcare, finance, and supply chain. Polkadot is worth to think about for its skill to allow connections between various blockchains, making a many-chain network that helps with growth. Avalanche gives fast, cheap deals with a flexible blockchain choice that attracts DeFi plans and businesses. Cardano l͏ooks at lasting growth and big size through its green proof-of-stake way, trying to bring shared apps to areas that lack them. These four projects mix quickness, size, real-world uses, and new ideas make them solid rivals to Solana with good chances for rise in the next months. So as the crypto field keeps changing and getting better experts suggest watching these Solana choices and thought about them for buying this holiday time. Why Lightchain AI Is More Than Just a Solana Alternative While Lightchain AI has been mentioned as a Solana alternative, it's more than just that. As the first blockchain project to combine AI and blockchain technology, Lightchain AI offers unique solutions for industries where these technologies can have a significant impact. Its Proof of Intelligence (PoI) consensus and Artificial Intelligence Virtual Machine (AIVM) make it stand out from traditional blockchains like Solana, which focus primarily on speed and scalability. With its presale priced at $0.003, experts believe Lightchain AI is an attractive investment opportunity with long-term growth potential beyond being compared to Solana. And as the demand for AI-driven decentralized applications grows, Lightchain AI could see significant adoption and success in the market. This makes it a top contender to watch in the crypto space, not just as an alternative to Solana but also as a project with its own unique potential for explosive growth. https://lightchain.ai https://lightchain.ai/lightchain-whitepaper.pdf https://x.com/LightchainAI https://t.me/LightchainProtocol Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp _____________ Disclaimer: Analytics Insight does not provide financial advice or guidance. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. You are responsible for conducting your own research (DYOR) before making any investments. Read more here.
By Africanews with AP Russian planes being loaded with trucks and equipment were seen on Tuesday in Qamishli airport in Hasaka, in what seems to be a withdraw of forces from northeastern Syria. Following the fall of Bashar Assad's government Russian forces and military vehicles were seen leaving Syria in the coastal city of Latakia. The British-based Syrian Observatory for Human Rights reported last week that Russian forces were leaving bases in Ain Issa and Tel Al-Samn near the northern city of Raqqa. Satellite images released by Maxar Technologies showed what appear to be cargo planes at a Russian military airfield in Syria with their nose cones opened to receive heavy equipment, along with helicopters being dismantled and prepared for transport. Moscow has reached out to the new Syrian authorities to try to ensure the security of its bases. Assad was overthrown by insurgent groups just over two weeks ago following a swift offensive that has shaken up the country’s alliances and led to celebrations in a nation long stifled by civil war.
The report from the Justice Department inspector general's office knocks down a fringe conspiracy theory advanced by some Republicans in Congress that the FBI played a role in instigating the events that day, when rioters determined to overturn Republican Donald Trump's 2020 election loss to Democrat Joe Biden stormed the building in a violent clash with police. The review, released nearly four years after a dark chapter in history that shook the bedrock of American democracy, was narrow in scope, but aimed to shed light on gnawing questions that have dominated public discourse, including whether major intelligence failures preceded the riot and whether the FBI in some way provoked the violence. The report offers a mixed assessment of the FBI's performance in the run-up to the riot, crediting the bureau for preparing for the possibility of violence and for trying to identify known "domestic terrorism subjects" who planned to come to Washington that day. But it said the FBI, in an action the now-deputy director described as a "basic step that was missed," failed to canvass informants across all 56 of its field offices for any relevant intelligence. That was a step, the report concluded, "that could have helped the FBI and its law enforcement partners with their preparations in advance of January 6." The report found 26 FBI informants were in Washington for election-related protests on Jan. 6, including three who were tasked with traveling to the city to report on others who were potentially planning to attend the day's events. While four informants entered the Capitol, none were authorized to do so by the bureau or to break the law, the report said. Many of the 26 informants provided the FBI with information before the riot, but it "was no more specific than, and was consistent with, other sources of information" that the FBI acquired. The FBI said in a letter responding to the report that it accepts the inspection general's recommendation "regarding potential process improvements for future events." The lengthy review was launched days after the riot as the FBI faced questions over whether it had missed warning signs or adequately disseminated intelligence it received, including a Jan. 5, 2021, bulletin prepared by the FBI's Norfolk, Virginia, field office that warned of the potential for "war" at the Capitol. The inspector general found the information in that bulletin was broadly shared. FBI Director Chris Wray, who announced this week his plans to resign at the end of Biden's term in January, defended his agency's handing of the intelligence report. He told lawmakers in 2021 that the report was disseminated though the joint terrorism task force, discussed at a command post in Washington and posted on an internet portal available to other law enforcement agencies. "We did communicate that information in a timely fashion to the Capitol Police and (Metropolitan Police Department) in not one, not two, but three different ways," Wray said at the time. Separately, the report said the FBI's New Orleans field office was told by a source between November 2020 and early January 2021 that protesters were planning to station a "quick reaction force" in northern Virginia "to be armed and prepared to respond to violence that day in DC, if necessary." That information was shared with the FBI's Washington Field Office, members of intelligence agencies and some federal law enforcement agencies the day before the riot, the inspector general found. But there was no indication the FBI told northern Virginia police about the information, the report said. An FBI official told the inspector general there was "nothing actionable or immediately concerning about it." A cache of weapons at a Virginia hotel as part of a "quick reaction force" was a central piece of the Justice Department's seditious conspiracy case against Oath Keeper leader Stewart Rhodes and other members of the far-right extremist group. The conspiracy theory that federal law enforcement officers entrapped members of the mob has been spread in conservative circles, including by some Republican lawmakers. Rep. Clay Higgins, R-La., recently suggested on a podcast that agents pretending to be Trump supporters were responsible for instigating the violence. Former Rep. Matt Gaetz, R-Fla., who withdrew as Trump's pick as attorney general amid scrutiny over sex trafficking allegations, sent a letter to Wray in 2021 asking how many undercover agents or informants were at the Capitol on Jan. 6 and if they were "merely passive informants or active instigators." Wray said the "notion that somehow the violence at the Capitol on January 6 was part of some operation orchestrated by FBI sources and agents is ludicrous."Jimmy Carter, 39th US president, Nobel winner, dies at 100Hundreds of trans patients admitted to hospital as women despite having conditions only suffered by MENEl presidente electo de Estados Unidos, Donald Trump, sube al escenario para pronunciar un discurso en los FOX Nation Patriot Awards, el 5 de diciembre de 2024, en Greenvale, Nueva York. (AP Foto/Heather Khalifa) FILE – Robert F. Kennedy, Jr., speaks before Republican presidential nominee former President Donald Trump at a campaign event, Sept. 27, 2024 in Walker, Mich. (AP Photo/Carlos Osorio) FILE – Former Florida Attorney General Pam Bondi, speaks before Republican presidential nominee former President Donald Trump at a campaign rally at First Horizon Coliseum, Nov. 2, 2024, in Greensboro, NC. (AP Photo/Alex Brandon, File) FILE – Mehmet Oz visits the AW Driving School & License Testing Center in Allentown, Pa., Sept. 23, 2022. (AP Photo/Matt Rourke, File) FILE – Former Rep. Doug Collins speaks before Republican presidential nominee former President Donald Trump at a campaign event at the Cobb Energy Performing Arts Centre, Oct. 15, 2024, in Atlanta. (AP Photo/John Bazemore, File) El presidente electo de Estados Unidos, Donald Trump, sube al escenario para pronunciar un discurso en los FOX Nation Patriot Awards, el 5 de diciembre de 2024, en Greenvale, Nueva York. (AP Foto/Heather Khalifa) By CHRISTINE FERNANDO CHICAGO (AP) — As Donald Trump’s Cabinet begins to take shape, those on both sides of the abortion debate are watching closely for clues about how his picks might affect reproductive rights policy in the president-elect’s second term . Trump’s cabinet picks offer a preview of how his administration could handle abortion after he repeatedly flip-flopped on the issue on the campaign trail. He attempted to distance himself from anti-abortion allies by deferring to states on abortion policy, even while boasting about nominating three Supreme Court justices who helped strike down the constitutional protections for abortion that had stood for half a century. In an NBC News interview that aired Sunday, Trump said he doesn’t plan to restrict medication abortion but also seemed to leave the door open, saying “things change.” “Things do change, but I don’t think it’s going to change at all,” he said. The early lineup of his new administration , including nominations to lead health agencies, the Justice Department and event the Department of Veterans Affairs, has garnered mixed — but generally positive — reactions from anti-abortion groups. Abortion law experts said Trump’s decision to include fewer candidates with deep ties to the anti-abortion movement could indicate that abortion will not be a priority for Trump’s administration. “It almost seems to suggest that President Trump might be focusing his administration in other directions,” said Greer Donley, an associate law professor at the University of Pittsburgh School of Law. Karen Stone, vice president of public policy at Planned Parenthood Action Fund , said while many of the nominees have “extensive records against reproductive health care,” some do not. She cautioned against making assumptions based on Trump’s initial cabinet selections. Still, many abortion rights groups are wary, in part because many of the nominees hold strong anti-abortion views even if they do not have direct ties to anti-abortion activists. They’re concerned that an administration filled with top-level officials who are personally opposed to abortion could take steps to restrict access to the procedure and funding. After Trump’s ambiguity about abortion during his campaign, “there’s still a lot we don’t know about what policy is going to look like,” said Mary Ruth Ziegler, a law professor at the University of California, Davis School of Law. That approach may be revealed as the staffs within key departments are announced. Trump announced he would nominate anti-vaccine activist Robert F. Kennedy Jr. to lead the Health and Human Services Department, which anti-abortion forces have long targeted as central to curtailing abortion rights nationwide. Yet Kennedy shifted on the issue during his own presidential campaign. In campaign videos, Kennedy said he supports abortion access until viability , which doctors say is sometime after 21 weeks, although there is no defined timeframe. But he also said “every abortion is a tragedy” and argued for a national ban after 15 weeks of pregnancy, a stance he quickly walked back. The head of Health and Human Services oversees Title X funding for a host of family planning services and has sweeping authority over agencies that directly affect abortion access, including the Food and Drug Administration and Centers for Medicare and Medicaid Services. The role is especially vital amid legal battles over a federal law known as EMTALA, which President Joe Biden’s administration has argued requires emergency abortion access nationwide, and FDA approval of the abortion pill mifepristone. Mini Timmaraju, president of the national abortion rights organization Reproductive Freedom for All, called Kennedy an “unfit, unqualified extremist who cannot be trusted to protect the health, safety and reproductive freedom of American families.” His potential nomination also has caused waves in the anti-abortion movement. Former Vice President Mike Pence , a staunch abortion opponent, urged the Senate to reject Kennedy’s nomination. Marjorie Dannenfelser, president of the national anti-abortion group Susan B. Anthony Pro-Life America, said the group had its own concerns about Kennedy. “There’s no question that we need a pro-life HHS secretary,” she said. Fox News correspondent Marty Makary is Trump’s pick to lead the FDA, which plays a critical role in access to medication abortion and contraception. Abortion rights groups have accused him of sharing misinformation about abortion on air. Russell Vought , a staunch anti-abortion conservative, has been nominated for director of the Office of Management and Budget. Vought was a key architect of Project 2025 , a right-wing blueprint for running the federal government. Among other actions to limit reproductive rights, it calls for eliminating access to medication abortion nationwide, cutting Medicaid funding for abortion and restricting access to contraceptive care, especially long-acting reversible contraceptives such as IUD’s. Despite distancing himself from the conservative manifesto on the campaign trail, Trump is stocking his administration with people who played central roles in developing Project 2025. Trump acknowledged that drafters of the report would be part of his incoming administration during the Sunday interview with NBC News, saying “Many of those things I happen to agree with.” “These cabinet appointments all confirm that Project 2025 was in fact the blueprint all along, and the alarm we saw about it was warranted,” said Amy Williams Navarro, director of government relations for Reproductive Freedom for All. Dr. Mehmet Oz , Trump’s choice to lead the Centers for Medicare and Medicaid Services, is a former television talk show host who has been accused of hawking dubious medical treatments and products. He voiced contradictory abortion views during his failed Senate run in 2022. Oz has described himself as “strongly pro-life, praised the Supreme Court decision overturning Roe v. Wade , claimed “life starts at conception” and referred to abortion as “murder.” But he also has echoed Trump’s states-rights approach, arguing the federal government should not be involved in abortion decisions. “I want women, doctors, local political leaders, letting the democracy that’s always allowed our nation to thrive to put the best ideas forward so states can decide for themselves,” he said during a Senate debate two years ago. An array of reproductive rights groups opposed his Senate run. As CMS administrator, Oz would be in a key position to determine Medicaid coverage for family planning services and investigate potential EMTALA violations. Related Articles National Politics | In promising to shake up Washington, Trump is in a class of his own National Politics | Election Day has long passed. In some states, legislatures are working to undermine the results National Politics | Trump taps his attorney Alina Habba to serve as counselor to the president National Politics | With Trump on the way, advocates look to states to pick up medical debt fight National Politics | Ballot recount confirms Woog’s win in House District 19 As Florida’s attorney general, Pam Bondi defended abortion restrictions, including a 24-hour waiting period. Now she’s Trump’s choice for attorney general . Her nomination is being celebrated by abortion opponents but denounced by abortion rights groups concerned she may revive the Comstock Act , an anti-vice law passed by Congress in 1873 that, among other things, bans mailing of medication or instruments used in abortion. An anti-abortion and anti-vaccine former Florida congressman, David Weldon, has been chosen to lead the Centers for Disease Control and Prevention, which collects and monitors abortion data across the country. Former Republican congressman Doug Collins is Trump’s choice to lead the Department of Veterans Affairs amid a political battle over abortion access and funding for troops and veterans. Collins voted consistently to restrict funding and access to abortion and celebrated the overturning of Roe v. Wade. “This is a team that the pro-life movement can work with,” said Kristin Hawkins, president of the national anti-abortion organization Students for Life.
DGRS: Good Fundamentals, But Subpar Dividend Growth
President Joe Biden mourns Jimmy Carters death, orders official state funeral to honor himRalph-Beyer puts up 20, Sacred Heart defeats Manhattanville 100-60
Biden is considering preemptive pardons for officials and allies before Trump takes office
AP Business SummaryBrief at 4:21 p.m. ESTMARLBOROUGH, Mass.--(BUSINESS WIRE)--Dec 9, 2024-- Hologic, Inc. (Nasdaq: HOLX) announced today that Martin Madaus has been elected to the Company’s Board of Directors, effective December 6, 2024. Dr. Madaus was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee effective December 6, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241209400549/en/ Dr. Martin Madaus (Photo: Business Wire) Dr. Madaus, who has more than 30 years of diagnostics and life sciences industry experience, currently serves as an Operating Executive at the Carlyle Group, a global investment firm, which he joined in February 2019. Prior to joining the Carlyle Group, Dr. Madaus held the role of Chairman and Chief Executive Officer at Ortho Clinical Diagnostics, Inc., a diagnostics company that makes products and diagnostic testing equipment for blood testing. Dr. Madaus previously served as the Chairman, President and Chief Executive Officer of Milipore Corporation, a life sciences company serving the bioscience research and biopharmaceutical manufacturing industry, until its acquisition by Merck KGaA in 2010. “We’re delighted to welcome Martin to Hologic’s Board of Directors,” said Steve MacMillan, Hologic’s Chairman, President and Chief Executive Officer. “With his deep industry, technical, business and international experiences, Martin represents yet another strong addition to our deep and experienced Board.” Dr. Madaus received a Doctor of Veterinary Medicine from the University of Munich in Germany and a Ph.D. in Veterinary Medicine from the Veterinary School of Hanover in Germany. About Hologic, Inc. Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com . Forward Looking Statements This press release contains forward-looking information that involves risks and uncertainties, including statements about the Company's plans, objectives, expectations and intentions, and statements regarding the Company's Board of Directors. These forward-looking statements are based on assumptions made by the Company as of this date and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. These risks include, but are not limited to, the risk that the Company may not be able to attract and retain qualified Board members or executives. These risks are not exhaustive. Other factors that could adversely affect the Company's business and prospects are described in the filings made by the Company with the SEC. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented here to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based. SOURCE: Hologic, Inc. View source version on businesswire.com : https://www.businesswire.com/news/home/20241209400549/en/ CONTACT: Investor Contact: Ryan Simon +1 858.410.8514 ryan.simon@hologic.comMedia Contact: Bridget Perry +1 508.263.8654 bridget.perry@hologic.com KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES CONSUMER WOMEN HEALTH TECHNOLOGY GENERAL HEALTH BIOTECHNOLOGY SOURCE: Hologic, Inc. Copyright Business Wire 2024. PUB: 12/09/2024 04:05 PM/DISC: 12/09/2024 04:05 PM http://www.businesswire.com/news/home/20241209400549/en
Baltimore Rep. Kweisi Mfume won’t attend Trump inauguration, citing MLK DayWatchdog finds FBI missteps before Jan. 6 riot, but no undercover agents were presentMinister for Communications and Information Technology, Prithvi Subba Gurung, has said that the government would not let anyone off named in the report of the Parliamentary Investigation Committee on Cooperative Fraud. Addressing the Tamu Journalism Award Distribution and Launching of the Gurung News.com Year Book Programme organized by Tamu (Gurung) Mediapersons' Association Nepal here today, Minister Gurung, who is also the government spokesman, expressed the government's determination to bring to justice anyone implicated in the cooperative fund misappropriation as per the report prepared by the Parliamentary Investigation Committee under lawmaker Surya Thapa's leadership. He said that no one was above the law and made it clear anybody whether they are the leaders or cadres of the Nepali Congress, the UML, Maoist or any other party would be brought to justice. Stating that all those named by lawmaker Thapa's report cannot be brought to justice simultaneously together now, Minister Gurung said, "We will not let off any one and take action against them turn by turn. Let those involved in cooperative fraud never think that they can escape the law. All will be arrested as per the law." He termed as unconstitutional the protest demonstration aimed at freeing Rabi Lamichhane, the President of Rastriya Swotantra Party (RSP), who is in police custody in connection with investigation process on the charge of cooperative fraud. The government spokesman also expressed his objection over such acts which according to him are carried out with the objective of influencing the case which is being considered by the court, calling attention of the sides concerned not to carry out activities that are against the democratic conduct and process. "It is the RSP's responsibility to cooperate in the investigation process against its leader. It is not at all appropriate to seek to influence the investigation process by organizing sit-in and protest demos, until the Respected Court gives its verdict. I urge RSP to stand on the side of the rule of law and the due process, rather than the undemocratic acts," Minister Gurung reiterated.
Richard Perry, Music Producer Behind Carly Simon’s ‘You’re So Vain,’ Dead at 82Mexico alters its laws and removes Chinese parts to stay in North American free trade pact
Spain, Germany hail Mercosur deal but France and EU farmers fumeCan Ethereum Break $3,500 Before End Of 2024, Discover the Top 7 Next Crypto to Explode Even FasterThe ever-changing landscape of cryptocurrency has made investors always on the lookout for potential returns. While Dogecoin (DOGE) has seen an interest boost, it still needs to determine whether it will cross $2 anytime soon. As the goal is to turn a $500 deposit into $7,500, a 15x increment of the initial investment, new and fundamentally sound cryptocurrencies must be identified well before DOGE crosses this threshold. Two such worth mentioning are Rexas Finance (RXS) and Stellar (XLM). Rexas Finance (RXS): Tokenized Asset Management Reimagined Rexas Finance is not just another entry into the cryptocurrency world but a complete transformation of the asset world. Owning portions of high-valued assets such as real estate and art pieces commodities via tokens will create a lower barrier to entry for many people while enhancing ownership of the assets at the same time. This innovation again increases market and investment opportunities for people worldwide. Rexas Finance's unique outlook has given the company a competitive edge, which has led to comparisons to Solana and Ethereum. In fact, some critics have even dubbed RXS's capabilities' The Solana Killer', as they may exceed and capture good traction in the market. Game-Changing Aspects Of RXS's Growth Rexas Finance is uniquely positioned by an array of features that automate the tokenization process and the tokens' issues. As such, these barriers to adoption are removed. The features include: Rexas Token Builder: A no-coding approach enables users to tokenize tangible assets without any technical knowledge, making it faster to enter the market. Rexas Launchpad: This is a tool for raising funds through the security of tokenized assets. In most cases, the asset owners raise the funds from a global pool of investors. AI-Powered Security: These smart contracts are monitored and secured automatically using artificial intelligence, thus protecting user assets from potential risks. Unprecedented Presale Success and Investor Enthusiasm There is a strong and positive feeling among the investors going into RXS. Rexas Finance, in its presales, has achieved tremendous feats, as seen in stage 10, quickly selling out to garner $30,738,031 and selling out a total of 364,084,594 tokens out of the 380,000,000 total supply. Such overwhelming demand among investors clearly accentuates the trust in the marketplace that RXS will transform conventional asset management systems. Investors Expect Opportunities For Unprecedented Growth Will Arise The prospects of RXS are appealing. Market analysts target $10 for the token by the beginning of 2025, an increase of over 150x its current presale price of $0.15. Such forward-looking statements expose RXS as a good investment choice compared to more mature and developed cryptocurrencies that have no particular viable room for growth. Stellar (XLM): Facilitating Seamless Cross-Border Transactions Stellar enables people to send and receive payments worldwide with a very low conversion rate. It appears to provide a method for receiving and sending funds while encouraging the growth of more financial networks. Presently, the current price of XLM is $0.42, its market value is $12.7 billion, and its market cap is over $30 billion. These measures mean Stellar's potential goes far beyond relying on financial institutions for its development and structure, allowing the banking ecosystem to integrate with systems built upon the cornerstone of blockchain technologies. According to expert predictions, demand for XLM's growth is likely to be driven by the necessity for XLM as a cross-border payment solution. Conclusion Despite several proponents' statements that Dogecoin may still reach $2, Stellar (XLM) and Rexas Finance (RXS) are undoubtedly more favorable for individuals seeking higher profits. More importantly, as for investors looking for the next big thing in the Cryptocurrency market, Rexas Finance is worth investigating. Its coveted position in the crypto space is due to its all-round approach to tokenizing real-world assets, offering a variety of selling features with a high level of security. Given the current buy rush on the first ten presale stages and analysts' forecasts of better times to come, investing in RXS could be interesting right now. Website: https://rexas.com Win $1 Million Giveaway: https://bit.ly/Rexas1M Whitepaper: https://rexas.com/rexas-whitepaper.pdf Twitter/X: https://x.com/rexasfinance Telegram: https://t.me/rexasfinance Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp _____________ Disclaimer: Analytics Insight does not provide financial advice or guidance. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. You are responsible for conducting your own research (DYOR) before making any investments. Read more here.
TeraWulf Inc. ( NASDAQ:WULF – Free Report ) – Investment analysts at Stifel Canada issued their Q4 2024 earnings estimates for TeraWulf in a research note issued to investors on Tuesday, December 24th. Stifel Canada analyst B. Papanastasiou expects that the company will post earnings per share of ($0.03) for the quarter. Stifel Canada has a “Moderate Buy” rating on the stock. The consensus estimate for TeraWulf’s current full-year earnings is ($0.17) per share. WULF has been the topic of a number of other reports. B. Riley lifted their target price on TeraWulf from $8.00 to $10.00 and gave the stock a “buy” rating in a report on Thursday, December 19th. Needham & Company LLC boosted their price objective on TeraWulf from $6.00 to $9.50 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Rosenblatt Securities reiterated a “buy” rating and issued a $10.00 target price on shares of TeraWulf in a report on Thursday, December 5th. Northland Securities restated an “outperform” rating and set a $10.00 price target on shares of TeraWulf in a report on Tuesday. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $11.00 price objective on shares of TeraWulf in a research note on Wednesday, December 4th. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, TeraWulf presently has a consensus rating of “Buy” and a consensus target price of $8.64. TeraWulf Stock Up 7.2 % NASDAQ WULF opened at $6.23 on Wednesday. TeraWulf has a 1 year low of $1.24 and a 1 year high of $9.30. The business’s fifty day moving average is $7.01 and its two-hundred day moving average is $5.36. Institutional Trading of TeraWulf Several institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC increased its stake in TeraWulf by 12.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,183,123 shares of the company’s stock valued at $33,623,000 after buying an additional 820,354 shares during the period. State Street Corp increased its stake in shares of TeraWulf by 3.8% in the third quarter. State Street Corp now owns 6,283,196 shares of the company’s stock worth $29,405,000 after acquiring an additional 227,186 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of TeraWulf during the second quarter worth $22,443,000. Hood River Capital Management LLC purchased a new position in TeraWulf in the second quarter valued at about $20,532,000. Finally, Charles Schwab Investment Management Inc. grew its stake in TeraWulf by 258.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,363,951 shares of the company’s stock valued at $11,063,000 after purchasing an additional 1,704,013 shares in the last quarter. 62.49% of the stock is currently owned by institutional investors and hedge funds. About TeraWulf ( Get Free Report ) TeraWulf Inc, together with its subsidiaries, operates as a digital asset technology company in the United States. The company develops, owns, and operates bitcoin mining facilities in New York and Pennsylvania. It is also involved in the provision of miner hosting services to third-party entities. The company was founded in 2021 and is headquartered in Easton, Maryland. Further Reading Receive News & Ratings for TeraWulf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TeraWulf and related companies with MarketBeat.com's FREE daily email newsletter .